4 completed, 1 terminated. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
Follow bedoradrine: new trials by email Literature Review of bedoradrine trials Research Report on bedoradrine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study to Evaluate MN-221 in Chronic Obstructive Pulmonary Disease (COPD) Patients MN-221, Placebo - Chronic Obstructive Pulmonary Disease | Phase 1 | Completed | MediciNova | 19 | 2012-03-01 | 2012-05-21 |
| Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) MN-221 (Dose Group 1), MN-221 (Dose Group 2), MN-221 (Dose Group 3) - Chronic Obstructive Pulmonary Disease | Phase 1 | Completed | MediciNova | 48 | 2009-11-01 | 2015-05-13 |
| Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma MN-221, Placebo - Asthma | Phase 2 | Completed | MediciNova | 176 | 2009-03-01 | 2013-09-05 |
| Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma Dose Group 1, MN-221 placebo, Dose Group 2 - Asthma, Status Asthmaticus | Phase 2 | Terminated | MediciNova | 29 | 2008-06-01 | 2011-10-07 |
| Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma MN-221, Placebo - Asthma | Phase 2 | Completed | MediciNova | 17 | 2008-02-01 | 2011-12-19 |
Asthma (3) · Pulmonary Disease, Chronic Obstructive (2) · Status Asthmaticus (1)
MediciNova (5)
United States (5)
Alan W Dunton, MD (1) · Kazuko Matsuda, MD (1) · Michael Kalafer (1) · Michael Kalafer, MD (1)